cjc 1295 no dac ipamorelin 5 5mg CJC-1295 (No DAC) + Peptide CJC1295/Ipamorelin (No DAC) - Apollo

IGF-1 LR3, however, can be administered exogenously to bypass this indirect process and produce faster results

Any intervention that chronically elevates GH and IGF-1 carries theoretical cancer risk concerns, since IGF-1 promotes cell proliferation and inhibits apoptosis

CJC 1295 binds to the GHRH receptor and activates the cAMP/PKA signaling cascade

It is proposed to work by binding GHRH receptors on pituitary somatotroph cells, prompting the pituitary to synthesize and release its own growth hormone in a pulsatile pattern, with the body's somatostatin feedback loop still intact so the effect is self-limiting rather than a constant hormone flood

This personalised approach ensures optimal results while minimising potential side effects, like tooth sensitivity